Investing Profile

R. Jacob Vogelstein

InvestorVCFounder
Co-Founder and Managing Partner at Catalio Capital Management
Photo of R. Jacob Vogelstein, Managing Partner at Catalio Capital
cb
Catalio Capital Managing Partner
$100K - $5.0M
$1.5M
8
CompanyStageDateRound SizeTotal Raised
Clasp Therapeutics
Series AMar 2024$150M
$150M
Co-investors: George C. Petrocheilos (Catalio Capital), Andrea van Elsas (Third Rock Ventures), Jack Nielsen (Vivo Capital)
NextPoint Therapeutics
Series BFeb 2024$43M
$120M
Co-investors: Paulina Hill (Polaris Partners), Detlev Biniszkiewicz (MPM Capital)
Iambic Therapeutics
Series BOct 2023$100M
Series AJul 2021$53M
$200M
Co-investors: Brian Keil (Alumni Ventures ), Kurt von Emster (Abingworth), Naren Gupta (Nexus Venture Partners), Ayman AlAbdallah
Haystack Oncology
Series ANov 2022$56M
$56M
Co-investors: George C. Petrocheilos (Catalio Capital)
Pheast Therapeutics
Series AApr 2022$76M
$76M
Co-investors: George C. Petrocheilos (Catalio Capital), Steven Gillis (ARCH Venture Partners)
Bayesian Health
Series UnknownJul 2021$15M
$15M
Co-investors: Vineeta Agarwala (Andreessen Horowitz), Julie Yoo (Andreessen Horowitz), Vijay Pande (Andreessen Horowitz)
eNeura Therapeutics
Series DFeb 2018$17M
$17M